Two Sigma Advisers’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-89,000
| Closed | -$9.55M | – | 2748 |
|
|
2023
Q1 | $9.55M | Sell |
89,000
-46,100
| -34% | -$4.95M | 0.02% | 564 |
|
|
2022
Q4 | $14.9M | Buy |
135,100
+5,100
| +4% | +$561K | 0.04% | 409 |
|
|
2022
Q3 | $7.67M | Buy |
130,000
+105,000
| +420% | +$6.2M | 0.02% | 573 |
|
|
2022
Q2 | $706K | Buy |
+25,000
| New | +$706K | ﹤0.01% | 1769 |
|